Updates are available Correction dated 2020-11-19
Click to view Correction: https://doi.org/10.1038/s41590-020-00843-8
-
Authors
Hartl, Frederike A.
Beck-Garcìa, Esmeralda
Woessner, Nadine M.
Flachsmann, Lea J.
Cárdenas, Rubí M.-H. Velasco
Brandl, Simon M. http://orcid.org/0000-0002-1632-0127
Taromi, Sanaz
Fiala, Gina J.
Morath, Anna
Mishra, Pankaj http://orcid.org/0000-0002-3487-6911
Yousefi, O. Sascha http://orcid.org/0000-0001-5304-729X
Zimmermann, Julia
Hoefflin, Nico
Köhn, Maja http://orcid.org/0000-0001-8142-3504
Wöhrl, Birgitta M.
Zeiser, Robert
Schweimer, Kristian http://orcid.org/0000-0002-3837-8442
Günther, Stefan http://orcid.org/0000-0003-3744-189X
Schamel, Wolfgang W. http://orcid.org/0000-0003-4496-3100
Minguet, Susana http://orcid.org/0000-0001-8211-5538
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB1160 P5, SFB850 C10, GSC-4, GSC-4, GSC-4, GSC-4, BIOSS - EXC294 and CIBSS - EXC 2189, IOSS - EXC294 and CIBSS - EXC 2189, GU1225/3-1, BIOSS - EXC294 and CIBSS - EXC 2189, SFB854 B19, SFB1381 A9)
Baden-Württemberg Stiftung (Eliteprogramm)
EC | Horizon 2020 Framework Programme (721358)
- License Information
-
More Information
Article History
Received: 29 May 2019
Accepted: 8 June 2020
First Online: 20 July 2020
Change Date: 19 November 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: F.A.H., W.W.S. and S.M. are listed as inventors on a patent application filed by the University of Freiburg (PCT/EP2020/058075) related to the use of the RK motif in immunotherapy against cancer. W.W.S. receives consulting income from TCR<sup>2</sup> therapeutics.
